论文信息 - A 52-week placebo-controlled trial of evolocumab in hyperlipidemia. - 字舞流文

A 52-week placebo-controlled trial of evolocumab in hyperlipidemia.

C. Ballantyne | E. Stein | R. Češka | S. Wasserman | R. Scott | M. Koren | M. Bolognese | Jae B. Kim | M. L. Monsalvo | D. Blom | P. Toth | E. Roth | L. Burgess | M. Lillestol | Kate Tsirtsonis | T. Hála | M. Monsalvo